The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
Open accessAbstract
We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012. Attributable death was defined as the difference in all-cause deaths between patients with carbapenem-resistant infections and those with carbapenem-susceptible infections. Online databases were searched, and data were qualitatively synthesized and pooled in a metaanalysis. Nine studies met inclusion criteria: 6 retrospective case-control studies, 2 retrospective cohort studies, and 1 prospective cohort study. Klebsiella pneumoniae was the causative pathogen in 8 studies; bacteremia was the only infection in 5 studies. We calculated that 26%-44% of deaths in 7 studies were attributable to carbapenem resistance, and in 2 studies, which included bacteremia and other infections, -3% and -4% of deaths were attributable to carbapenem resistance. Pooled outcomes showed that the number of deaths was significantly higher in patients with carbapenem-resistant infections and that the number of deaths attributable to carbapenem resistance is considerable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement
Clsi (2010) · Cited by 987
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Patel, G., Huprikar, S., Factor, S. H., Jenkins, S. G., & Calfee, D. P. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/592412 · Cited by 836
Schwaber, M. J., & Carmeli, Y. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm318 · Cited by 626
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Schwaber, M. J., Klarfeld-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-07 · Cited by 483
Zarkotou, O., Pournaras, S., Tselioti, P., Dragoumanos, V., Pitiriga, V., Ranellou, K., Prekates, A., Themeli-Digalaki, K., & Tsakris, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03514.x · Cited by 438
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
Ben-David, D., Kordevani, R., Keller, N., Tal, I., Marzel, A., Gal-Mor, O., Maor, Y., & Rahav, G. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03478.x · Cited by 353
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Gasink, L. B., Edelstein, P. H., Lautenbach, E., Synnestvedt, M., & Fishman, N. O. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/648451 · Cited by 306
Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M. J., & Carmeli, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00299-07 · Cited by 256
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study
Falagas, M. E., Rafailidis, P. I., Kofteridis, D. P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm356 · Cited by 253
Self-citationRottier, W. C., Ammerlaan, H. S. M., & Bonten, M. J. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks065 · Cited by 225
Hussein, K., Sprecher, H., Mashiach, T., Oren, I., Kassis, I., & Finkelstein, R. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/598244 · Cited by 215
Daikos, G. L., Petrikkos, P., Psichogiou, M., Kosmidis, C., Vryonis, E., Skoutelis, A., Georgousi, K., Tzouvelekis, L. S., Tassios, P. T., Bamia, C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00782-08 · Cited by 210
Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in France
Cuzon, G., Ouanich, J., Gondret, R., Naas, T., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01452-10 · Cited by 209
Vardakas, K. Z., Rafailidis, P. I., Konstantelias, A. A., & Falagas, M. E. (2013) · Journal of Infection · doi:10.1016/j.jinf.2012.10.028 · Cited by 202
Self-citationMouloudi, E. K., Protonotariou, E., Zagorianou, A., Iosifidis, Ε., Karapanagiotou, A., Giasnetsova, T., Tsioka, A., Roilides, E., Sofianou, D., & Gritsi-Gerogianni, N. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/657135 · Cited by 171
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167
Self-citationClonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece
Pournaras, S., Protonotariou, E., Voulgari, E., Kristo, I., Dimitroulia, E., Vitti, D., Tsalidou, M., Maniatis, A. N., Tsakris, A., & Sofianou, D. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp207 · Cited by 147
Gregory, C. J., Llata, E., Stine, N. W., Gould, C., Santiago, L. M., Vázquez, G. J., Robledo, I. E., Srinivasan, A., Goering, R. V., & Tomashek, K. M. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651670 · Cited by 104
Endimiani, A., Carias, L. L., Hujer, A. M., Bethel, C. R., Hujer, K. M., Pérez, F., Hutton, R. A., Fox, W. R., Hall, G. S., Jacobs, M. R., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00158-08 · Cited by 101
Steinmann, J., Kaase, M., Gatermann, S. G., Popp, W., Steinmann, E., Damman, M., Paul, A., Saner, F. H., Buer, J., & Rath, P. ‐. (2011) · Eurosurveillance · doi:10.2807/ese.16.33.19944-en · Cited by 89
Borer, A., Eskira, S., Nativ, R., Saidel‐Odes, L., Riesenberg, K., Livshiz‐Riven, I., Schlaeffer, F., Sherf, M., & Peled, N. (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/662620 · Cited by 77
Hu, F., Chen, S., Xu, X., Guo, Y. P., Liu, Y., Zhu, D., & Zhang, Y. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.036483-0 · Cited by 73
Jeon, M., Choi, S., Kwak, Y. G., Chung, J.-W., Lee, S., Jeong, J., Woo, J. H., & Kim, Y. S. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.08.014 · Cited by 68
Balkhy, H. H., El‐Saed, A., Johani, S. M. A., Francis, C., Al-Qahtani, A. A., Al‐Ahdal, M. N., Tayeb, H. T., Arabi, Y. M., Alothman, A. F., & Sallah, M. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1519-0 · Cited by 54
Zhang, R., Wang, X., Cai, J., Zhou, H. W., Huo-xiang, L., Hu, Q. F., & Chen, G. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.015826-0 · Cited by 36
Cited by
Xu, L., Sun, X., & Ma, X. (2017) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-017-0191-3 · Cited by 661
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Doi, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz830 · Cited by 652
Diekema, D. J., Hsueh, P.-R., Mendes, R. E., Pfaller, M. A., Rolston, K. V., Sader, H. S., & Jones, R. N. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00355-19 · Cited by 645
Kadri, S. S., Adjemian, J., Lai, Y. L., Spaulding, A. B., Ricotta, E., Prevots, D. R., Palmore, T. N., Rhee, C., Klompas, M., Dekker, J. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy378 · Cited by 605
Terreni, M., Taccani, M., & Pregnolato, M. (2021) · Molecules · doi:10.3390/molecules26092671 · Cited by 596
Metadata
- Authors
- Falagas, M. E., Tansarli, G. S., Karageorgopoulos, D. E., & Vardakas, K. Z.
- Venue
- Emerging Infectious Diseases
- Published
- 2014-07
- Volume
- 20
- Issue
- 7
- Pages
- 1170-1175
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W1984903487
- Cited by
- 514
- References
- 29
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.